Analyzing...
Loading company...
HealthCare Global Enterprises Ltd. provides imaging and diagnostics services for cancer treatment. The company is headquartered in Bangalore, Karnataka and currently employs 5,679 full-time employees. The company went IPO on 2016-03-30. The firm is involved retail sale of pharmaceuticals, medical and orthopedic goods and toilet articles. The company operates cancer care network under the HCG brand. The company operates infertility treatment clinics providing assisted reproductive services under brand Milann. The firm operates eight Milann fertility centers, which provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. Milann fertility centers also offer training programs for fertility specialists and embryologists. Under the Triesta brand, it provides clinical reference laboratory services with specialization in oncology.
Nothing flagged for monitoring
“Services business in Healthcare — Hospitals & Diagnostics.”
₹2,545 Cr service revenue.
Employee costs at 14.9% of revenue — primary cost driver.
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 1.0%▼ | 9.0% |
| ROCE | 6.9%▼ | 10.4% |
| Net Margin | 0.5%▼ | 8.5% |
| EBITDA Margin | 17.4%▼ | 20.6% |
| Debt To Equity | 0.68x▲ | 0.16x |
| Rev Growth 3yr | 14.6%▲ | 14.4% |
| EPS Growth 3yr | -22.7%▼ | 9.9% |
| Employee Cost Ratio | 14.90x | - |
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2,545 Cr +14.5% | ₹2,223 Cr +16.3% | ₹1,912 Cr +12.8% | ₹1,694 Cr +21.2% | ₹1,398 Cr +37.9% | ₹1,013 Cr -7.5% | ₹1,096 Cr +12.3% | ₹976 Cr |
| Other Income | ₹25 Cr -28.2% | ₹35 Cr +105.5% | ₹17 Cr +28.5% | ₹13 Cr +4.0% | ₹13 Cr -25.3% | ₹17 Cr +143.2% | ₹7 Cr -30.7% | ₹10 Cr |
| Total Income | ₹2,570 Cr +13.9% | ₹2,258 Cr +17.0% | ₹1,929 Cr +13.0% | ₹1,708 Cr +21.1% | ₹1,410 Cr +36.9% | ₹1,030 Cr -6.5% | ₹1,103 Cr +11.8% | ₹986 Cr |
| COGS | ₹692 Cr +19.2% | ₹581 Cr +22.1% | ₹475 Cr +12.1% | ₹424 Cr +19.5% | ₹355 Cr +47.7% | ₹240 Cr +0.2% | ₹240 Cr +9.7% | ₹219 Cr |
| ₹2,500 Cr +13.6% | ₹2,201 Cr +18.0% | ₹1,866 Cr +12.2% | ₹1,663 Cr +17.4% | ₹1,416 Cr +21.5% | ₹1,165 Cr -3.7% | ₹1,210 Cr +19.9% | ₹1,008 Cr | |
| Profit Before Tax | ₹25 Cr -54.7% | ₹56 Cr -16.5% | ₹67 Cr +50.0% | ₹45 Cr -49.7% | ₹89 Cr ↑ Recovery | (₹228 Cr) -113.5% | (₹107 Cr) -377.4% | (₹22 Cr) |
| Exceptional Items | (₹45 Cr) | ₹0.00 Cr -100.0% | ₹4 Cr | ₹0.00 Cr -100.0% | ₹95 Cr ↑ Recovery | (₹93 Cr) | ₹0.00 Cr | ₹0.00 Cr |
| ₹4 Cr -49.1% | ₹8 Cr -69.2% | ₹26 Cr -3.1% | ₹27 Cr -44.2% | ₹49 Cr ↑ Recovery | (₹8 Cr) ↓ Decline | ₹6 Cr ↑ Recovery | (₹3 Cr) | |
| Net Profit | ₹23 Cr -53.3% | ₹49 Cr +18.2% | ₹41 Cr +134.5% | ₹18 Cr -54.7% | ₹39 Cr ↑ Recovery | (₹221 Cr) -76.2% | (₹125 Cr) -306.3% | (₹31 Cr) |
| Profit (Owners) | ₹14 Cr -69.0% | ₹44 Cr -7.7% | ₹48 Cr +64.1% | ₹29 Cr -45.4% | ₹54 Cr ↑ Recovery | (₹193 Cr) -81.3% | (₹107 Cr) -330.2% | (₹25 Cr) |
| Minority Interest | ₹9 Cr +104.1% | ₹4 Cr ↑ Recovery | (₹7 Cr) +41.8% | (₹12 Cr) +20.9% | (₹15 Cr) +46.4% | (₹28 Cr) -47.3% | (₹19 Cr) -208.6% | (₹6 Cr) |
| Other Comprehensive Income | ₹5 Cr +152.8% | ₹2 Cr ↑ Recovery | (₹0.47 Cr) +64.4% | (₹1 Cr) +13.7% | (₹2 Cr) ↓ Decline | ₹0.59 Cr +22.9% | ₹0.48 Cr ↑ Recovery | (₹3 Cr) |
| EPS | ₹0.93 | ₹3.01 | ₹3.26 | ₹1.99 | ₹3.65 | (₹14.58) | (₹11.36) | (₹2.66) |
| Diluted Shares | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹13 Cr | ₹9 Cr | ₹9 Cr |
| Profit Or Loss Of Associates | ₹1 Cr +89.6% | ₹0.77 Cr +97.4% | ₹0.39 Cr ↑ Recovery | (₹0.02 Cr) +98.6% | (₹1 Cr) -300.0% | (₹0.36 Cr) +97.1% | (₹12 Cr) -12.2% | (₹11 Cr) |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Healthcare Global Enterprises Limited has informed the Exchange about Schedule of meet
Healthcare Global Enterprises Limited has informed the Exchange about Copy of Newspaper Publication
Healthcare Global Enterprises Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Healthcare Global Enterprises Limited has informed the Exchange that further to the intimation dated May 19, 2026, with respect to the approval of the Board of Directors of Company granted on May 19, ...
Hector Asia Holdings II Pte. Ltd. has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeove...
Healthcare Global Enterprises Limited has informed the Exchange about Copy of Newspaper Publication
Healthcare Global Enterprises Limited has informed the Exchange about Transcript of the Earnings Call held on May 20, 2026, with Analysts/Investors to discuss the Audited Financial Results (both Stand...
Healthcare Global Enterprises Limited has informed the Exchange about Copy of Newspaper Publication of Audited Financial Results of the company.
Healthcare Global Enterprises Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
Healthcare Global Enterprises Limited has informed the Exchange regarding launch of its new comprehensive cancer hospital in Hebbal with up to 132 beds, strengthening access to advanced oncology care ...
Healthcare Global Enterprises Limited has informed the Exchange regarding a press release dated May 19, 2026, titled "HealthCare Global Enterprises Limited (HCG), India s largest dedicated cancer hosp...
Monitoring Agency Report for the quarter ended March 31, 2026 - in relation to the Rights Issue of the Company.
Healthcare Global Enterprises Limited has informed the Exchange about Earnings Conference Call that has been scheduled on Wednesday, May 20, 2026, at 01.30 p.m. (IST), to discuss the Audited Financial...
Healthcare Global Enterprises Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Healthcare Global Enterprises Limited has informed the Exchange about Copy of Newspaper Publication in respect of Special Window for Transfer and Dematerialization of Physical Securities of the Compan...
No dividend history available for this company.